288 related articles for article (PubMed ID: 32793216)
1. Immune Evasion Strategies of Relapsing Fever Spirochetes.
Röttgerding F; Kraiczy P
Front Immunol; 2020; 11():1560. PubMed ID: 32793216
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional interaction of CihC/FbpC orthologs of relapsing fever spirochetes with host-derived proteins involved in adhesion, fibrinolysis, and complement evasion.
Damm AS; Reyer F; Langhoff L; Lin YP; Falcone FH; Kraiczy P
Front Immunol; 2024; 15():1390468. PubMed ID: 38726006
[TBL] [Abstract][Full Text] [Related]
3. Dual binding specificity of a Borrelia hermsii-associated complement regulator-acquiring surface protein for factor H and plasminogen discloses a putative virulence factor of relapsing fever spirochetes.
Rossmann E; Kraiczy P; Herzberger P; Skerka C; Kirschfink M; Simon MM; Zipfel PF; Wallich R
J Immunol; 2007 Jun; 178(11):7292-301. PubMed ID: 17513779
[TBL] [Abstract][Full Text] [Related]
4. Relapsing fever spirochetes Borrelia recurrentis and B. duttonii acquire complement regulators C4b-binding protein and factor H.
Meri T; Cutler SJ; Blom AM; Meri S; Jokiranta TS
Infect Immun; 2006 Jul; 74(7):4157-63. PubMed ID: 16790790
[TBL] [Abstract][Full Text] [Related]
5. Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity.
Grosskinsky S; Schott M; Brenner C; Cutler SJ; Kraiczy P; Zipfel PF; Simon MM; Wallich R
PLoS One; 2009; 4(3):e4858. PubMed ID: 19308255
[TBL] [Abstract][Full Text] [Related]
6. The Borrelia hermsii factor H binding protein FhbA is not required for infectivity in mice or for resistance to human complement in vitro.
Fine LM; Miller DP; Mallory KL; Tegels BK; Earnhart CG; Marconi RT
Infect Immun; 2014 Aug; 82(8):3324-32. PubMed ID: 24866803
[TBL] [Abstract][Full Text] [Related]
7. Elucidating the Immune Evasion Mechanisms of
Walter L; Sürth V; Röttgerding F; Zipfel PF; Fritz-Wolf K; Kraiczy P
Front Immunol; 2019; 10():2722. PubMed ID: 31849943
[No Abstract] [Full Text] [Related]
8. Human complement regulators C4b-binding protein and C1 esterase inhibitor interact with a novel outer surface protein of Borrelia recurrentis.
Grosskinsky S; Schott M; Brenner C; Cutler SJ; Simon MM; Wallich R
PLoS Negl Trop Dis; 2010 Jun; 4(6):e698. PubMed ID: 20532227
[TBL] [Abstract][Full Text] [Related]
9. Complement evasion strategies of Borrelia burgdorferi sensu lato.
Dulipati V; Meri S; Panelius J
FEBS Lett; 2020 Aug; 594(16):2645-2656. PubMed ID: 32748966
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of the interaction of Borrelia parkeri and Borrelia turicatae with human complement regulators.
Schott M; Grosskinsky S; Brenner C; Kraiczy P; Wallich R
Infect Immun; 2010 May; 78(5):2199-208. PubMed ID: 20231403
[TBL] [Abstract][Full Text] [Related]
11. The genome of Borrelia recurrentis, the agent of deadly louse-borne relapsing fever, is a degraded subset of tick-borne Borrelia duttonii.
Lescot M; Audic S; Robert C; Nguyen TT; Blanc G; Cutler SJ; Wincker P; Couloux A; Claverie JM; Raoult D; Drancourt M
PLoS Genet; 2008 Sep; 4(9):e1000185. PubMed ID: 18787695
[TBL] [Abstract][Full Text] [Related]
12. Host Immune Evasion by Lyme and Relapsing Fever Borreliae: Findings to Lead Future Studies for
Stone BL; Brissette CA
Front Immunol; 2017; 8():12. PubMed ID: 28154563
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Immunological Responses to
Curtis MW; Krishnavajhala A; Kneubehl AR; Embers ME; Gettings JR; Yabsley MJ; Lopez JE
Microbiol Spectr; 2022 Jun; 10(3):e0172221. PubMed ID: 35579456
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of a linear-plasmid-encoded factor H-binding protein (FhbA) of the relapsing fever spirochete Borrelia hermsii.
Hovis KM; McDowell JV; Griffin L; Marconi RT
J Bacteriol; 2004 May; 186(9):2612-8. PubMed ID: 15090501
[TBL] [Abstract][Full Text] [Related]
15. CD55 Facilitates Immune Evasion by Borrelia crocidurae, an Agent of Relapsing Fever.
Arora G; Lynn GE; Tang X; Rosen CE; Hoornstra D; Sajid A; Hovius JW; Palm NW; Ring AM; Fikrig E
mBio; 2022 Oct; 13(5):e0116122. PubMed ID: 36036625
[TBL] [Abstract][Full Text] [Related]
16. Conformational dynamics of complement protease C1r inhibitor proteins from Lyme disease- and relapsing fever-causing spirochetes.
Roy S; Booth CE; Powell-Pierce AD; Schulz AM; Skare JT; Garcia BL
J Biol Chem; 2023 Aug; 299(8):104972. PubMed ID: 37380082
[TBL] [Abstract][Full Text] [Related]
17. Immunological and molecular analyses of the Borrelia hermsii factor H and factor H-like protein 1 binding protein, FhbA: demonstration of its utility as a diagnostic marker and epidemiological tool for tick-borne relapsing fever.
Hovis KM; Schriefer ME; Bahlani S; Marconi RT
Infect Immun; 2006 Aug; 74(8):4519-29. PubMed ID: 16861638
[TBL] [Abstract][Full Text] [Related]
18. Borrelia persica infection in dogs and cats: clinical manifestations, clinicopathological findings and genetic characterization.
Baneth G; Nachum-Biala Y; Halperin T; Hershko Y; Kleinerman G; Anug Y; Abdeen Z; Lavy E; Aroch I; Straubinger RK
Parasit Vectors; 2016 May; 9(1):244. PubMed ID: 27160515
[TBL] [Abstract][Full Text] [Related]
19. Roles for phagocytic cells and complement in controlling relapsing fever infection.
Woodman ME; Cooley AE; Avdiushko R; Bowman A; Botto M; Wooten RM; van Rooijen N; Cohen DA; Stevenson B
J Leukoc Biol; 2009 Sep; 86(3):727-36. PubMed ID: 19458267
[TBL] [Abstract][Full Text] [Related]
20. Immune evasion of Borrelia miyamotoi: CbiA, a novel outer surface protein exhibiting complement binding and inactivating properties.
Röttgerding F; Wagemakers A; Koetsveld J; Fingerle V; Kirschfink M; Hovius JW; Zipfel PF; Wallich R; Kraiczy P
Sci Rep; 2017 Mar; 7(1):303. PubMed ID: 28331202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
